Correlation Between Shimmick Common and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Shimmick Common and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shimmick Common and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shimmick Common and Tscan Therapeutics, you can compare the effects of market volatilities on Shimmick Common and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shimmick Common with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shimmick Common and Tscan Therapeutics.
Diversification Opportunities for Shimmick Common and Tscan Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Shimmick and Tscan is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Shimmick Common and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Shimmick Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shimmick Common are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Shimmick Common i.e., Shimmick Common and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Shimmick Common and Tscan Therapeutics
Given the investment horizon of 90 days Shimmick Common is expected to generate 1.09 times more return on investment than Tscan Therapeutics. However, Shimmick Common is 1.09 times more volatile than Tscan Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 197.00 in Shimmick Common on September 2, 2024 and sell it today you would earn a total of 38.00 from holding Shimmick Common or generate 19.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Shimmick Common vs. Tscan Therapeutics
Performance |
| Timeline |
| Shimmick Common |
| Tscan Therapeutics |
Shimmick Common and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Shimmick Common and Tscan Therapeutics
The main advantage of trading using opposite Shimmick Common and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shimmick Common position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Shimmick Common vs. Magna International | Shimmick Common vs. Rivian Automotive | Shimmick Common vs. Li Auto | Shimmick Common vs. Modine Manufacturing |
| Tscan Therapeutics vs. Tff Pharmaceuticals | Tscan Therapeutics vs. Eliem Therapeutics | Tscan Therapeutics vs. Inhibrx | Tscan Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |